Want to hire this expert for a project? Request a quote for free.
Profile Details
Hire Dr. Francesco R.
Canada
Scientific Writer & Data Analyst | Expertise in Research Support, Data Visualization & Presentation Creation
Profile Summary
Subject Matter Expertise
Services
Writing
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing,
Creative Writing,
General Proofreading & Editing
Research
Meta-Research,
Fact Checking,
Gap Analysis,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Healthcare Consulting,
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Analysis,
Data Visualization,
Big Data Analytics
Work Experience
Postdoctorate
University Health Network, Toronto, Canada
March 2024 - March 2025
Postdoctorate
University of Rome Tor Vergata
February 2022 - March 2024
PhD Fellow
University of Rome Tor Vergata
November 2018 - February 2022
Education
PhD Molecular Biology
University of Roma "Tor Vergata" - Italy
November 2018 - February 2022
Certifications
-
Scientific Writing for Research Grant Proposals
University of Colorado
March 2025 - Present
-
Design and Interpretation of Clinical Trials
John Hopkins University
March 2025 - Present
-
Excel for Data Analysis
IBM
February 2025 - Present
-
Introduction to Data Analytics
IBM
February 2025 - Present
-
ICH GOOD CLINICAL PRACTICE
The Global Health Network
February 2025 - Present
Publications
JOURNAL ARTICLE
E. Foffi, A. Violante, R. Pecorari, A. M. Lena, F. Rugolo, G. Melino, E. Candi (2024). BRD4 sustains p63 transcriptional program in keratinocytes . Biology Direct.
Manuela Montanaro, Massimiliano Agostini, lucia anemona, Elena Bonanno, Francesca Servadei, Enrico Finazzi Agrò, Anastasios D. Asimakopoulos, Carlo Ganini, Chiara Cipriani, Marta Signoretti, et al. (2023). ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer . International Journal of Molecular Sciences.
Francesco Rugolo, Nicolas G. Bazan, Jorgelina Calandria, Bokkyoo Jun, Giuseppe Raschellà, Gerry Melino, Massimiliano Agostini (2022). Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome . Oncogene.
Francesco Rugolo, Nicolas G. Bazan, Jorgelina Calandria, Bokkyoo Jun, Giuseppe Raschellà, Gerry Melino, Massimiliano Agostini (2021). The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome . Oncogene.
Francesco Rugolo and Nicolas G. Bazan and Jorgelina Calandria and Bokkyoo Jun and Giuseppe Raschell{\`{a}} and Gerry Melino and Massimiliano Agostini(2021). The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome . Oncogene. 40. (38). p. 5741--5751. Springer Science and Business Media {LLC}
Alessio Butera and Matteo Cassandri and Francesco Rugolo and Massimiliano Agostini and Gerry Melino(2020). The ZNF750–RAC1 axis as potential prognostic factor for breast cancer . Cell Death Discovery. 6. (1). Springer Science and Business Media {LLC}